Mesoblast (MESO) EBIT (2014 - 2023)
Mesoblast (MESO) recorded EBIT of $258.44 million in the year ended Jun 30, 2026, up 199.9% from $86.18 million a year earlier.
Analysis
Mesoblast (MESO) EBIT (2014 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's EBIT history includes 12 years.
- The figure for the year ended Jun 30, 2026 is the highest annual EBIT in data going back to the year ended Jun 30, 2015.
- Per Business Quant data, MESO's EBIT was $86.18 million in the year ended Jun 30, 2025 (+22.1%), $70.6 million in the year ended Jun 30, 2024 (-19.6%), $87.8 million in the year ended Jun 30, 2023 and -$108.87 million in the year ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.04 Bn | 1,100.62 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 614.86 Bn | 533.39 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.14 Bn | 321.52 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.69 Bn | 235.37 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.43 Bn | 191.82 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.90 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Mesoblast | 1.67 Bn | 1.24 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -17.51 Mn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | -18.37 Mn |
| Sep 30, 2022 | -12.39 Mn |
| Jun 30, 2022 | -17.17 Mn |
| Mar 31, 2022 | -17.44 Mn |
| Dec 31, 2021 | -20.65 Mn |
| Sep 30, 2021 | -18.57 Mn |
| Jun 30, 2021 | -23.28 Mn |
| Mar 31, 2021 | -22.66 Mn |
| Dec 31, 2020 | -21.62 Mn |
| Sep 30, 2020 | -21.35 Mn |
| Jun 30, 2020 | -32.06 Mn |
| Mar 31, 2020 | -13.49 Mn |
| Dec 31, 2019 | -23.25 Mn |
| Sep 30, 2019 | -3.84 Mn |
| Jun 30, 2019 | -20.11 Mn |
| Mar 31, 2019 | -24.03 Mn |
| Dec 31, 2018 | -24.98 Mn |
| Sep 30, 2018 | -17.56 Mn |
API Access
Mesoblast EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=MESO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();